Blenrep’s Comeback Continues As England Becomes First To Fund Drug

Blenrep was recently approved as a second-line treatment for multiple myeloma in combination with other drugs (Shutterstock)
Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

More from Health Technology Assessment

More from Product Reviews